Voss et al. (2017) described that MCT4 is enriched in areas of tumor hypoxia and that an inhibition of MCT4 binding to its chaperon basigin strongly inhibited tumor progression of glioblastoma stem cells [36]. The gene discussed is BSG; the disease is neoplasm.